FDA recall D-1225-2014

Agila Specialties Private Ltd. · Class II · drug

Product

etomidate injection, USP, 2 mg/mL, packaged in a) 20 mg/10 mL (2 mg/mL), 10 mL Single Dose Vials (NDC 0069-0006-02), 10 x 10 mL vials per carton (NDC 0069-0006-01) and b) 40 mg/20 mL (2 mg/mL) 20 mL Single Dose Vials (NDC 0069-0006-04), 10 x 20 mL vials per carton (NDC 0069-0006-03), Rx only, Distributed by Pfizer Labs; Division of Pfizer Inc., New York, NY 10017.

Reason for recall

Presence of Particulate Matter: Potential for small black particles to be present in individual vials, the potential for missing lot number and/or expiry date on the outer carton and the potential for illegible/missing lot number and expiry on individual vials.

Distribution

Nationwide and Puerto Rico

Key facts

Status
Terminated
Initiation date
2014-02-14
Report date
2014-04-16
Termination date
2015-12-03
Voluntary/Mandated
Voluntary: Firm initiated
Location
Bangalore, Karnataka, N/A, India

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-1225-2014